Related Experiment Video
Updated: Nov 21, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Coenzyme Q10 in COPD: An Unexplored Opportunity?
V I Zozina1, S Covantev2, V G Kukes1
1Department of Clinical Pharmacology and Propaedeutics of Internal Diseases, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Coenzyme Q10 may help manage Chronic Obstructive Pulmonary Disease (COPD) by addressing oxidative stress. Further research is needed to confirm its benefits for COPD patients and their common comorbidities.
Area of Science:
- Pulmonary Medicine
- Biochemistry
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death and illness globally.
- COPD involves systemic inflammation, oxidative stress, and protease-antiprotease imbalance.
- Mitochondrial dysfunction and oxidative stress are key in COPD, but coenzyme Q10's role is understudied.
Purpose of the Study:
- To review current data on coenzyme Q10 for COPD management.
- To assess coenzyme Q10's potential in treating COPD comorbidities.
Main Methods:
- Literature review of studies on coenzyme Q10 and COPD.
- Analysis of existing research on coenzyme Q10's effects on oxidative stress and inflammation in COPD.
Main Results:
- Limited data exists on coenzyme Q10's efficacy in COPD.
- Oxidative stress is a significant factor in COPD pathogenesis.
Conclusions:
- Coenzyme Q10 warrants further investigation for COPD treatment.
- Potential benefits for managing COPD and associated conditions exist.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
07:35Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation